Early Mobilization of Spiral Metacarpal Fractures Compared With Operative Treatment

July 9, 2021 updated by: Uppsala University

Early Mobilization of Spiral Metacarpal Fractures Compared With Operative Treatment - a Prospective Randomized Trial

Spiral metacarpal fractures (metacarpal II-V) can be treated conservatively or with operation. With minimal displacement this fracture is usually treated with immobilisation or early mobilisation. With appreciable displacement especially any malrotation the patient usually is treated with an operation. This usually includes an open reduction of the fracture and fixation with plates and screws or just screws. Even if this is an standard procedure both mild and severe complications have been reported. New studies have shown that even displaced fractures can be treated with early mobilization. In those cases the fractures may heal with some shortening but very good function. An advantage of early mobilization is that the patient avoids the risk of an operation and the costs for the treatment are decreased markedly. The study is designed to answer the question if early mobilization is not inferior to operative treatment but with lower costs and without any operation related risks.

Study Overview

Status

Completed

Conditions

Detailed Description

The study is designed as an prospective, randomised controlled trial. The patients are divided into two groups (operative and conservative treatment with early mobilisation). The operative group is treated with internal fixation and 2 weeks in a cast. The conservative group is instructed to do a fist to correct any malrotation and to rehabilitate quickly. By this procedure shortening oft he metacarpalfractures is limited by the function of the deep transverse metacarpal ligament connecting the distal parts of the metacarpalbones II-V. Furthermore the participants in the conservative group are allowed to use their hands without any restrictions. A physiotherapist controls that early mobilisation is carried out.

The participant will be seen for a follow-up at 1, 6 and 12 weeks and 1 year. Radiographs will be performed at 1v and 6v. The finger ranges of motion and pain will be evaluated with every follow-up, DASH score, range of motion, pain and grip-strength will be measured after 12v and 1 year. The investigators will measure return to driving, work and sport.

Complications will be registered continuously for all patients. The overall satisfaction of the patients and the costs for both treatments will be documented as well.

The study population is planned to be 21 patients in each group.

Study Type

Interventional

Enrollment (Actual)

42

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Dalarna
      • Falun, Dalarna, Sweden, 79182
        • Falu lasarett, Department of Orthopedics
    • Uppsala Län
      • Uppsala, Uppsala Län, Sweden, 75185
        • Uppsala University Hospital, Dept. of Handsurgery

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • single spiral fractures of metacarpal bone II-V
  • fracture line at least twice the length of the diameter of the bone at the level of the fracture
  • at least 1-2mm displacement of the fracture and/or malrotation
  • normal hand function before the injury
  • fracture less than 10 days old

Exclusion Criteria:

  • multiple metacarpal fractures
  • open fractures
  • incompliance or dementia
  • fracture line not twice the length of the diameter of the bone at the level of the fracture
  • abnormal hand function before the injury
  • fracture more than 10 days old

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: conservative group
Treatment with early mobilisation

Conservative treatment with early mobilisation

The patient is instructed to do a fist and is not allowed to leave the clinic before. Active mobilisation under control (doctor or physiotherapist) is performed until healing of the fracture is documented.

Other: operative group
Treatment with operation
Operation of the fracture. Usually open reduction and internal fixation with plates and screws or just screws within 2 weeks of injury. Immobilisation in a cast for two weeks followed by physiotherapy.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Grip-strength measured by the JAMAR dynamometer
Time Frame: 1 year
Power of the treated hand measured by the JAMAR dynamometer compared with the none-operated hand
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Handfunction rated by the DASH-score
Time Frame: 1 year
DASH-score
1 year
Range of motion in the treated hand/fingerray
Time Frame: 1 year
Range of motion in the treated hand measured in degrees of active motion with a hand held goniometer (operated fingerray)
1 year
Appearance and severity of complications
Time Frame: 1 year
Complications during the different treatments
1 year
Time until the patient can return to work, driving and sport
Time Frame: 1 year
Return to work, driving and sport
1 year
The total costs of each treatment
Time Frame: 1 year
Costs of each treatment
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Nils Hailer, Professor, Department of Orthopedics, Uppsala University Hospital
  • Principal Investigator: Daniel Muder, MD, Dr. med., Department of Orthopedics, Falu lasarett
  • Principal Investigator: Grey Giddins, M.B.B.Ch. F.R.C.S. (Orth), Royal United Hospitals Bath NHS Foundation Trust

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2017

Primary Completion (Actual)

May 28, 2021

Study Completion (Actual)

May 28, 2021

Study Registration Dates

First Submitted

February 21, 2017

First Submitted That Met QC Criteria

February 24, 2017

First Posted (Actual)

March 1, 2017

Study Record Updates

Last Update Posted (Actual)

July 16, 2021

Last Update Submitted That Met QC Criteria

July 9, 2021

Last Verified

July 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • FOU 2017-0056

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fracture

Clinical Trials on Early mobilisation

Subscribe